Health Catalyst (HCAT) News Today $4.47 +0.01 (+0.22%) Closing price 04:00 PM EasternExtended Trading$4.57 +0.10 (+2.33%) As of 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Health Catalyst: Share Price Continues To Dismiss Positive Earnings And Improved OutlookMarch 25 at 4:14 PM | seekingalpha.comCritical Comparison: Health Catalyst (NASDAQ:HCAT) and Cloudastructure (NASDAQ:CSAI)March 23 at 2:11 AM | americanbankingnews.comPalogic Value Management L.P. Invests $2.26 Million in Health Catalyst, Inc. (NASDAQ:HCAT)Palogic Value Management L.P. purchased a new position in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 320,000 shares of the company's stock, valMarch 22 at 5:55 AM | marketbeat.comPrimecap Management Co. CA Has $13.66 Million Stock Holdings in Health Catalyst, Inc. (NASDAQ:HCAT)Primecap Management Co. CA reduced its position in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 19.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,932,617 shares of the company's stock after selling 471,845 shares during the period. Primecap ManagemMarch 21, 2025 | marketbeat.comHealth Catalyst, Inc. (NASDAQ:HCAT) Shares Purchased by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. boosted its stake in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 93.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 254,762 shares ofMarch 19, 2025 | marketbeat.comBank of New York Mellon Corp Has $10.16 Million Stock Position in Health Catalyst, Inc. (NASDAQ:HCAT)Bank of New York Mellon Corp cut its position in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 37.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,437,006 shares oMarch 14, 2025 | marketbeat.comJ.P. Morgan Reaffirms Their Buy Rating on Health Catalyst (HCAT)March 13, 2025 | markets.businessinsider.comAlphaQuest LLC Purchases 83,213 Shares of Health Catalyst, Inc. (NASDAQ:HCAT)AlphaQuest LLC boosted its position in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 1,989.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 87,395 shares of the company's stock after acquiriMarch 12, 2025 | marketbeat.comBenjamin Landry Sells 13,827 Shares of Health Catalyst, Inc. (NASDAQ:HCAT) StockHealth Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) General Counsel Benjamin Landry sold 13,827 shares of the firm's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $4.55, for a total transaction of $62,912.85. Following the sale, the general counsel now owns 160,437 shares of the company's stock, valued at approximately $729,988.35. This represents a 7.93 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.March 11, 2025 | marketbeat.comInsider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) COO Sells 16,902 Shares of StockHealth Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) COO Daniel Lesueur sold 16,902 shares of Health Catalyst stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $4.52, for a total transaction of $76,397.04. Following the completion of the transaction, the chief operating officer now directly owns 216,250 shares of the company's stock, valued at $977,450. This trade represents a 7.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.March 11, 2025 | marketbeat.comHealth Catalyst Announces ~$5 Million Stock RepurchaseMarch 11, 2025 | prnewswire.comInsider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) General Counsel Sells 13,827 Shares of StockMarch 11, 2025 | insidertrades.com10 Analysts Have This To Say About Health CatalystMarch 8, 2025 | nasdaq.com1 Software Stock with Exciting Potential and 2 to IgnoreMarch 8, 2025 | finance.yahoo.comStephens Has Lowered Expectations for Health Catalyst (NASDAQ:HCAT) Stock PriceStephens reduced their price objective on shares of Health Catalyst from $7.00 to $5.00 and set an "equal weight" rating for the company in a research note on Thursday.March 7, 2025 | marketbeat.comHealth Catalyst price target lowered to $5 from $7 at StephensMarch 6, 2025 | markets.businessinsider.comHealth Catalyst, Inc. (NASDAQ:HCAT) Given Average Rating of "Moderate Buy" by AnalystsShares of Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) have been assigned an average rating of "Moderate Buy" from the eleven ratings firms that are presently covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold rating and eight have issued a buy ratingMarch 5, 2025 | marketbeat.comHealth Catalyst Full Year 2024 Earnings: EPS Misses ExpectationsMarch 4, 2025 | finance.yahoo.comHealth Catalyst (NASDAQ:HCAT) Price Target Cut to $6.00 by Analysts at Royal Bank of CanadaRoyal Bank of Canada cut their target price on Health Catalyst from $7.00 to $6.00 and set a "sector perform" rating on the stock in a research note on Thursday.February 28, 2025 | marketbeat.comStifel Nicolaus Has Lowered Expectations for Health Catalyst (NASDAQ:HCAT) Stock PriceStifel Nicolaus cut their price target on Health Catalyst from $10.00 to $5.00 and set a "hold" rating on the stock in a research note on Thursday.February 28, 2025 | marketbeat.comHealth Catalyst (NASDAQ:HCAT) Earns Equal Weight Rating from StephensStephens reissued an "equal weight" rating and issued a $7.00 price objective on shares of Health Catalyst in a research note on Thursday.February 28, 2025 | marketbeat.comQ4 2024 Health Catalyst Inc Earnings CallFebruary 28, 2025 | uk.finance.yahoo.comHealth Catalyst, Inc.: Health Catalyst Reports Fourth Quarter and Year End 2024 ResultsFebruary 28, 2025 | finanznachrichten.deHealth Catalyst announces multiyear agreement with Signature HealthFebruary 28, 2025 | markets.businessinsider.comEvercore ISI Remains a Buy on Health Catalyst (HCAT)February 28, 2025 | markets.businessinsider.comHealth Catalyst (NASDAQ:HCAT) Announces Quarterly Earnings Results, Misses Estimates By $0.24 EPSHealth Catalyst (NASDAQ:HCAT - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.13) earnings per share for the quarter, missing analysts' consensus estimates of $0.11 by ($0.24). Health Catalyst had a negative net margin of 26.20% and a negative return on equity of 7.51%.February 27, 2025 | marketbeat.comHealth Catalyst (HCAT) Receives a Hold from RBC CapitalFebruary 27, 2025 | markets.businessinsider.comHealth Catalyst price target lowered to $10 from $13 at BTIGFebruary 27, 2025 | markets.businessinsider.comWhy Health Catalyst (HCAT) Shares Are Trading Lower TodayFebruary 27, 2025 | msn.comSignature Healthcare to Enhance Analytics by Leveraging Health Catalyst Ignite™February 27, 2025 | prnewswire.comHealth Catalyst (HCAT) Gets a Buy from William BlairFebruary 27, 2025 | markets.businessinsider.comHealth Catalyst, Inc. (HCAT) Q4 2024 Earnings Call TranscriptFebruary 26, 2025 | seekingalpha.comHealth Catalyst reports Q4 EPS 4c, consensus 8cFebruary 26, 2025 | markets.businessinsider.comHealth Catalyst sees Q1 revenue $79M, consensus $81.88MFebruary 26, 2025 | markets.businessinsider.comHealth Catalyst’s (NASDAQ:HCAT) Q4 Earnings Results: Revenue In Line With Expectations, Growth To Accelerate Next YearFebruary 26, 2025 | finance.yahoo.comHealth Catalyst Reports Fourth Quarter and Year End 2024 ResultsFebruary 26, 2025 | globenewswire.comHealth Catalyst (HCAT) Q4 Earnings: What To ExpectFebruary 25, 2025 | msn.comEarnings To Watch: Health Catalyst Inc (HCAT) Reports Q4 2024 ResultFebruary 25, 2025 | finance.yahoo.comHealth Catalyst, Inc. (NASDAQ:HCAT) Shares Acquired by Impax Asset Management Group plcImpax Asset Management Group plc raised its position in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 7.7% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,750,000 shares of the company's stock after buying an additional 19February 25, 2025 | marketbeat.comHealth Catalyst, Inc. (NASDAQ:HCAT) Insider Linda Llewelyn Sells 6,441 SharesHealth Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) insider Linda Llewelyn sold 6,441 shares of Health Catalyst stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $5.43, for a total transaction of $34,974.63. Following the completion of the transaction, the insider now directly owns 85,819 shares of the company's stock, valued at approximately $465,997.17. This represents a 6.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.February 21, 2025 | marketbeat.comHealth Catalyst (HCAT) Expected to Announce Earnings on WednesdayHealth Catalyst (NASDAQ:HCAT) will be releasing earnings after the market closes on Wednesday, February 26. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=662662)February 19, 2025 | marketbeat.comHealth Catalyst to Participate in Upcoming Investor ConferenceFebruary 18, 2025 | globenewswire.comMartin & Co. Inc. TN Has $3.47 Million Stake in Health Catalyst, Inc. (NASDAQ:HCAT)Martin & Co. Inc. TN increased its stake in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 80.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 490,998 shares of the company's stock afteFebruary 17, 2025 | marketbeat.comHealth Catalyst, Inc. (NASDAQ:HCAT) Short Interest UpdateHealth Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) saw a large decrease in short interest in the month of January. As of January 31st, there was short interest totalling 2,010,000 shares, a decrease of 21.5% from the January 15th total of 2,560,000 shares. Based on an average daily volume of 656,600 shares, the days-to-cover ratio is currently 3.1 days.February 16, 2025 | marketbeat.comPiper Sandler cuts Health Catalyst price target to $8, keeps overweightFebruary 11, 2025 | msn.comHealth Catalyst price target lowered to $8 from $12 at Piper SandlerFebruary 11, 2025 | markets.businessinsider.comHealth Catalyst (NASDAQ:HCAT) Price Target Lowered to $8.00 at Piper SandlerPiper Sandler dropped their price target on shares of Health Catalyst from $12.00 to $8.00 and set an "overweight" rating for the company in a research note on Tuesday.February 11, 2025 | marketbeat.comHealth Catalyst, Inc. (NASDAQ:HCAT) Shares Sold by Janney Montgomery Scott LLCJanney Montgomery Scott LLC trimmed its holdings in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 55.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 49,496 shares of the company's stock after sellingFebruary 11, 2025 | marketbeat.comHealth Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) have earned a consensus rating of "Moderate Buy" from the ten analysts that are covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and eight have given a buy recommeFebruary 8, 2025 | marketbeat.comHealth Catalyst COO sells $30,007 in stockFebruary 7, 2025 | msn.com Remove Ads Get Health Catalyst News Delivered to You Automatically Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter. Email Address HCAT Media Mentions By Week HCAT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HCAT News Sentiment▼1.260.63▲Average Medical News Sentiment HCAT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HCAT Articles This Week▼54▲HCAT Articles Average Week Remove Ads Get Health Catalyst News Delivered to You Automatically Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DAVA News NYAX News QUBT News COUR News EVER News FSLY News BBAI News MOMO News DCBO News BLND News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HCAT) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Catalyst, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Catalyst With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
